Yahoo

LANXESS (XTRA:LXS) Stock May Look Reasonable Given Its Sales Pressure

LANXESS has seen its share price come under heavy pressure in recent years, which puts a fresh spotlight on whether the current valuation can still be explained by its sales base. For anyone considering the stock today, the key issue is how that price compares with what the company actually generates in revenue.

  • Over the past 5 years the share price has fallen 78.2%, which puts the focus squarely on whether the market is now assigning a very different value to each euro of LANXESS sales.

  • The business model relies heavily on converting specialty chemicals revenue into sustainable cash flow, so production efficiency, pricing discipline and capital intensity may all influence how much investors are willing to pay for its sales.

  • Your read on LANXESS is one view; the desks covering it have another. See what analysts think LANXESS's shares could be worth .

The issue now is whether the current LANXESS share price is appropriately supported by its sales when judged against the Fair Ratio benchmark.

If you want to test the same sales-based valuation question beyond LANXESS, compare it with 194 high quality undervalued stocks .

Does LANXESS Look Undervalued on Sales?

P/S suits LANXESS because the discussion here is already about what investors pay for each euro of revenue. On that measure, the stock trades on a P/S of 0.2x, compared with an industry average of about 1.2x and a peer group around 1.1x. That is a wide gap in how the market values each euro of sales in this business versus the broader chemicals sector.

The Fair Ratio model, which adjusts for LANXESS specific mix of growth expectations, margins, size and risk, points to a higher P/S than where the shares change hands today. That places the current P/S below the level suggested by this more tailored yardstick, which indicates the shares screen as undervalued on sales compared with what the framework would imply for the company. Explore the numbers behind LANXESS's P/S valuation .

XTRA:LXS P/S Ratio as at Oct 2026
XTRA:LXS P/S Ratio as at Oct 2026

The LANXESS Narrative: What Would Justify Today's Price?

Narratives for LANXESS pick up where the valuation gap leaves off and set out, in plain terms, what combination of future growth, profit margins and earnings power would need to hold for the shares to be worth meaningfully more or less than today. Rather than giving a single number, they describe the future that number rests on so you can watch how the real business lines up with those assumptions over time. These are available on Simply Wall St's Community page.

The LANXESS community splits between those who see a cleaner, more focused chemicals group taking shape and those who think execution and demand risk still dominate.

Bull case: 23% undervalued

"Strategic portfolio optimization, including the divestiture of the urethane business and closure of high cost, high CO2 assets, positions LANXESS toward higher margin, resilient segments..."

Discover why this Narrative puts LANXESS at 23% undervalued .

Bear case: 7% overvalued

"Although LANXESS has delivered sizeable FORWARD! program savings, new rounds of job cuts and network optimization risk coming too late to offset prolonged sub 70% utilization..."

Explore why this Narrative puts LANXESS at 7% overvalued .

One more angle on LANXESS that could shift your view

Valuation only tells part of the LANXESS story, since recent checks from Simply Wall St also highlight specific issues that merit closer inspection before you rely on the headline multiples. Take a closer look at 1 major warning sign before settling on a valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include LXS.DE .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: